Metraipolis › archive › dc_922a4e046c4e

Liraglutide combined with dapagliflozin treatment improves myocardial disease and endothelial dysfunction in T2DM mice — Europe PMC PMID:42394413

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42394413
DOI
10.1111/jdi.70363
License (as archived)
solo-consultazione
Archived
2026-10-18T11:35:18.755Z
SHA-256 of the archived text
c28482163c5e66f6bc6e0686abf413d71eee704e230643174485be78855dc1b9
Stable URL of this page
https://metraipolis.com/documento/dc_922a4e046c4e

How to cite

Liraglutide combined with dapagliflozin treatment improves myocardial disease and endothelial dysfunction in T2DM mice — Europe PMC PMID:42394413 — Europe PMC (en), https://europepmc.org/article/MED/42394413 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_922a4e046c4e (Metraipolis archive dc_922a4e046c4e, sha256 c28482163c5e66f6bc6e0686abf413d71eee704e230643174485be78855dc1b9)
BibTeX
@misc{dc922a4e046c4e,
  title = {Liraglutide combined with dapagliflozin treatment improves myocardial disease and endothelial dysfunction in T2DM mice — Europe PMC PMID:42394413},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42394413},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_922a4e046c4e; sha256 c28482163c5e66f6bc6e0686abf413d71eee704e230643174485be78855dc1b9},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42394413. Agents can read the archived copy with the MCP tool read_document.